000			02061 a2200493 4500
005			20250518043834.0
264		0	_c20200422
008			202004s 0 0 eng d
022			_a1532-0987
024	7		_a10.1097/INF.0000000000002345 _2doi
040			_aNLM _beng _cNLM
100	1		_aChanthavanich, Pornthep
245	0	0	_aSafety, Tolerability and Immunogenicity of an MF59-adjuvanted, Cell Culture-derived, A/H5N1, Subunit Influenza Virus Vaccine: Results From a Dose-finding Clinical Trial in Healthy Pediatric Subjects. _h[electronic resource]
260			_bThe Pediatric infectious disease journal _c07 2019
300			_a757-764 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
650	0	4	_aAdjuvants, Immunologic _xadministration & dosage
650	0	4	_aAdolescent
650	0	4	_aAntibodies, Viral _xblood
650	0	4	_aChild
650	0	4	_aChild, Preschool
650	0	4	_aDrug-Related Side Effects and Adverse Reactions _xepidemiology
650	0	4	_aFemale
650	0	4	_aHealthy Volunteers
650	0	4	_aHemagglutination Inhibition Tests
650	0	4	_aHumans
650	0	4	_aInfant
650	0	4	_aInfluenza A Virus, H5N1 Subtype _ximmunology
650	0	4	_aInfluenza Vaccines _xadministration & dosage
650	0	4	_aInfluenza, Human _xprevention & control
650	0	4	_aMale
650	0	4	_aPolysorbates _xadministration & dosage
650	0	4	_aSingle-Blind Method
650	0	4	_aSqualene _xadministration & dosage
650	0	4	_aUnited States
650	0	4	_aVaccines, Subunit _xadministration & dosage
700	1		_aAnderson, Edwin
700	1		_aKerdpanich, Phirangkul
700	1		_aBulitta, Michael
700	1		_aKanesa-Thasan, Niranjan
700	1		_aHohenboken, Matthew
773	0		_tThe Pediatric infectious disease journal _gvol. 38 _gno. 7 _gp. 757-764
856	4	0	_uhttps://doi.org/10.1097/INF.0000000000002345 _zAvailable from publisher's website
999			_c29794026 _d29794026